1. Cousins MJ, Brennan F, Carr DB. Pain relief: a universal human right. Pain. 2004; 112:1–4. PMID:
15494176.
Article
2. Bolash R, Udeh B, Saweris Y, Guirguis M, Dalton JE, Makarova N, et al. Longevity and cost of implantable intrathecal drug delivery systems for chronic pain management: a retrospective analysis of 365 patients. Neuromodulation. 2015; 18:150–155. PMID:
25250852.
Article
3. Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011; 11:770. PMID:
21978149.
Article
4. Breivik H, Eisenberg E, OBrien T. OPENMinds. The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health. 2013; 13:1229. PMID:
24365383.
Article
5. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10:287–333. PMID:
16095934.
Article
6. Smith BH, Torrance N. Management of chronic pain in primary care. Curr Opin Support Palliat Care. 2011; 5:137–142. PMID:
21415754.
Article
7. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther. 2005; 7:R1046–R1051. PMID:
16207320.
8. Wallace M, Yaksh TL. Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med. 2000; 25:117–157. PMID:
10746527.
Article
9. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery. 1999; 44:289–300. PMID:
9932882.
Article
10. Paice JA, Winkelmüller W, Burchiel K, Racz GB, Prager JP. Clinical realities and economic considerations: efficacy of intrathecal pain therapy. J Pain Symptom Manage. 1997; 14:S14–S26. PMID:
9291707.
Article
11. Deer TR, Krames E, Levy RM, Hassenbusch SJ 3rd, Prager JP. Practice choices and challenges in the current intrathecal therapy environment: an online survey. Pain Med. 2009; 10:304–309. PMID:
19254334.
Article
12. Kim EJ, Moon JY, Kim YC, Park KS, Yoo YJ. Intrathecal morphine infusion therapy in management of chronic pain: present and future implementation in Korea. Yonsei Med J. 2016; 57:475–481. PMID:
26847303.
Article
13. The Korean Pain Society. Textbook of pain medicine. 4th ed. Seoul: Shinwon Medical;2012. p. 469–480.
14. Tracey I, Bushnell MC. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain. 2009; 10:1113–1120. PMID:
19878862.
Article
15. Hamza M, Doleys D, Wells M, Weisbein J, Hoff J, Martin M, et al. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med. 2012; 13:1304–1313. PMID:
22845187.
Article
16. Auld AW, Maki-Jokela A, Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine (Phila Pa 1976). 1985; 10:777–781. PMID:
3841231.
Article
17. Turner JA, Sears JM, Loeser JD. Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications. Clin J Pain. 2007; 23:180–195. PMID:
17237668.
Article
18. Duarte RV, Raphael JH, Haque MS, Southall JL, Ashford RL. A predictive model for intrathecal opioid dose escalation for chronic non-cancer pain. Pain Physician. 2012; 15:363–369. PMID:
22996848.
19. Atli A, Theodore BR, Turk DC, Loeser JD. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up. Pain Med. 2010; 11:1010–1016. PMID:
20492572.
Article
20. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol. 2001; 55:79–86. PMID:
11301086.
Article
21. Grider JS, Harned ME, Etscheidt MA. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain. Pain Physician. 2011; 14:343–351. PMID:
21785477.
22. Konrad PE, Huffman JM, Stearns LM, Plunkett RJ, Grigsby EJ, Stromberg EK, et al. Intrathecal drug delivery systems (IDDS): the implantable systems performance registry (ISPR). Neuromodulation. 2016; 19:848–856. PMID:
27730704.
Article
23. Mueller-Schwefe G, Hassenbusch SJ, Reig E. Cost effectiveness of intrathecal therapy for pain. Neuromodulation. 1999; 2:77–87. PMID:
22151111.
Article